Meet the Management Team

Jerrell W. Shelton

President and Chief Executive Officer, Cryoport, Inc.

Jerrell Shelton has more than 30 years of executive and corporate governance experience across several industries including information services, telecommunications, manufacturing and distribution. Previously, he was a visiting executive at IBM Research, where his team created and developed WebFountain, a project contributing significantly to IBM’s software strategy. He was also president and CEO of NDC Holdings, Continental Graphics Holdings, Thomson Business Information Group and Advantage Companies. Under his leadership, each of those companies achieved rapid revenue growth, improved profitability and increased shareholder value. Shelton holds a B.S.B.A. degree from the University of Tennessee and an MBA from Harvard Business School.

Robert S. Stefanovich

CHIEF FINANCIAL OFFICER, TREASURER AND CORPORATE SECRETARY, Cryoport. Inc.

Robert Stefanovich has more than 20 years of experience in financial management, including more than a decade as a senior-level financial executive in the health care and technology industries. Stefanovich has served as CFO of Novalar Pharmaceuticals, a venture-backed specialty pharmaceutical company. Previously, he served as the CFO of three publicly traded companies including Xcorporeal, a medical device company, Artemis International Solutions Corporation, a software company, and Aethlon Medical, a medical device company. Previously, he was vice president of administration at SAIC, a Fortune 500 company. Stefanovich also served as a member of the Software Advisory Group and as audit manager with Price Waterhouse LLP’s (now PricewaterhouseCoopers) technology practice in San Jose, Calif., and Frankfurt, Germany. He currently serves as a board member of Project InVision International, a leading provider of business performance improvement solutions. He received his master’s degree in business administration and engineering from the University of Darmstadt in Germany.

Mark W. Sawicki, Ph.D.

Chief Scientific Officer, Cryoport, Inc.

Mark Sawicki brings 15 years of business development and sales management experience, having consistently delivered on corporate revenue and market share goals in the pharmaceutical and biotechnology industries. Sawicki was most recently the chief business officer at AAIPharma Services Corporation/Cambridge Major Laboratories Inc. Additionally, he has served in senior business development roles at CMC Biologics and Albany Molecular Research Inc. (AMRI), where he increased revenue at rates far outpacing industry standards. Sawicki holds a bachelor’s in biochemistry from the State University of New York at Buffalo and a Ph.D. in biochemistry from the State University of New York at Buffalo, School of Medicine and Biomedical Sciences. He also received graduate training at the Hauptman Woodard Medical Research Institute. Sawicki has authored a dozen scientific publications in drug discovery with a focus on oncology and immunology.

Thomas J. Heinzen

VICE PRESIDENT OF CORPORATE DEVELOPMENT, Cryoport, Inc.

Thomas Heinzen brings over 23 years of executive experience in investment banking and equity trading to Cryoport. Prior to joining Cryoport in 2015, Heinzen was the head of trading at Protective Group Securities and later a senior vice president at Emergent Financial Group. He currently serves as chairman of the board for Spire Credit Union. Heinzen held series 4, 7, 55, 63 and 65 securities licenses and has a bachelor’s degree in finance from the University of St. Thomas.

Mark W. Sawicki, Ph.D.

President & CEO

Mark Sawicki brings 15 years of business development and sales management experience, having consistently delivered on corporate revenue and market share goals in the pharmaceutical and biotechnology industries. Sawicki was most recently the chief business officer at AAIPharma Services Corporation/Cambridge Major Laboratories Inc. Additionally, he has served in senior business development roles at CMC Biologics and Albany Molecular Research Inc. (AMRI), where he increased revenue at rates far outpacing industry standards. Sawicki holds a bachelor’s in biochemistry from the State University of New York at Buffalo and a Ph.D. in biochemistry from the State University of New York at Buffalo, School of Medicine and Biomedical Sciences. He also received graduate training at the Hauptman Woodard Medical Research Institute. Sawicki has authored a dozen scientific publications in drug discovery with a focus on oncology and immunology.

Phil Wilson

Chief Operating Officer

Phil Wilson is an accomplished supply chain executive with over 25 years of industry experience. Prior to joining Cryoport, Phil served as Vice President, Supply Chain for Ancillare LP and before that, as the Director of Global Operational Programs at Catalent Pharma Solutions, where he managed all aspects of the pharmaceutical supply chain. He holds a Master’s Degree in Supply Chain Management from Pennsylvania State University and is currently focusing his post graduate work in Clinical Trial Management from Temple University School of Pharmacy. He also holds multiple compliance certifications, including Transportation and Logistics by APICS (CTL), Business Continuity Professional by the DRI International, Certified by the IATA/FIATA as an Air Cargo Transportation Specialist, and licensed by the United States Treasury Department as a Customs Broker.

Aruna Mor

Chief Commercial Officer

Aruna Mor is an accomplished, results-driven business executive with over 20 years of experience in the Life Sciences. She has extensive experience in managing and leading a comprehensive team from the top down globally, including P&L management, sales and business development, business strategy, product marketing (B2B and B2C), product management, marketing communications, brand strategy, go-to-market strategies, brand and product launches, and commercialization for portfolios with over $1B in revenue. She has a proven track record of driving business growth and profitability through strategic initiatives and innovative solutions. Aruna is an expert in identifying, evaluating, and executing organic and inorganic growth opportunities and developing a strategic roadmap to achieve operational, financial, and strategic goals. She has led several successful M&A initiatives that resulted in increased market share and revenue growth.

Aruna was most recently the Senior Vice President of Global Marketing and Business Development (Americas) at KBI Biopharma, where she was responsible for establishing and driving sales and marketing for KBI, building a world-class team to accomplish long-term business goals that drive strategic growth. She is an expert in leading Onmi-channel marketing and delivering successful campaigns by measuring effectiveness through the right KPIs.

Before joining KBI, Aruna led marketing efforts at TriLink Biotechnologies as Head of Global Marketing, where she managed the full scope of marketing and strategy. She has served in various marketing, sales, business development, and product management roles at Becton Dickinson, Zymo Research, and Thermo Fisher Scientific, routinely managing more than $1B in revenue. Aruna has successfully launched and managed the product life cycle for over 150 products and services throughout her career. Previously, she held positions as a Bioinformatics Engineer at the National Cancer Institute (NCI) and the National Institutes of Health (NIH).

In addition to managing multi-million-dollar projects and growth, Aruna has received several industry awards for her leadership and her exceptional marketing campaigns and strategies. Aruna holds an MBA from USCD’s Rady School, an MS in Bioinformatics from George Mason University, and an MS in Biology from India, where she also received her Bachelor’s degree in Biology.

Bret Bollinger

CHIEF TECHNOLOGY OFFICER

Bret Bollinger has an extensive background in domestic and international manufacturing environments, along with experience in new product design and implementation. Prior to joining Cryoport, Bollinger was director of operations and engineering for Triangle Brass Manufacturing. Prior to that, he served as a business process consultant for Cardinal Health and served as operations and order fulfillment manager for Ingersoll-Rand's Falcon Lock Company. Bollinger holds a bachelor’s in mechanical engineering from Sacramento State University.

Michael Dybicz

Sr. Vice President and Chief Product Development Officer

Michael Dybicz brings over 25 years of experience in product, process, and strategy execution across a variety of industries. He is a hands-on analytical and entrepreneurial executive focused on creating, building, and growing sustainable companies and teams. Mr. Dybicz brings a diverse background from developing groundbreaking advanced text analytics software as a service (precursor to Watson called WebFountain) at IBM Research to experience with multiple healthcare service companies with innovative models of care (SmartRoom, LivingWell, Medically Home). He has managed and run multiple boutique management advisory firms focused on management consulting, serving as interim executive, developing corporate strategies, and crafting go-to-market plans across healthcare, technology, and other industries. He lived in Eastern Europe for 3 years helping to run and restructure a Venture Capital Fund and established a comprehensive due diligence and financial analysis framework to relaunch the Fund. Having a B.S. in Biomedical Engineering from Rensselaer Polytechnic Institute and an M.B.A/M.S.I.A. from the Tepper School/Graduate School of Industrial Administration at Carnegie Mellon University, Mr. Dybicz strives to innovate, challenge, and deploy service and product solutions that scale and create real value solving tangible problems.

Keith Boothroyd

Vice President of Finance

Keith Boothroyd has more than 20 years of financial leadership experience in the Medical Device industry while working at Edwards Lifesciences.  Keith is the current Vice Chair of the Dean’s Leadership Circle at the Paul Merage School of Business at the University of California, Irvine.  Keith is a Certified Management Accountant (CMA) and a Certified Public Accountant (CPA). He received his MBA and BA in Economics at the University of California, Irvine.

Adam Fox

VICE PRESIDENT OF QUALITY ASSURANCE AND REGULATORY AFFAIRS

Adam Fox brings more than 30 years of pharmaceutical, biopharmaceutical and medical device industry experience to Cryoport. During leadership positions at organizations such as Nitto Avecia Pharma Services, Teva Pharmaceuticals and Boehringer Ingelheim, Adam earned valuable regulatory and compliance experience and knowledge through his collaborative interactions with various regulating bodies. With a Bachelor of Science in microbiology and chemistry from The Ohio State University and a Bachelor of Science in pharmacy from Ohio Northern University, Adam adds value by bridging quality and compliance with science.

Rob Jones

Vice President of Global Bioservices

Rob is an accomplished supply chain executive with over 30 years of commercial development experience and 10 years’ laboratory experience in the blood transfusion industry. Qualified in haematology and blood transfusion science, he originally worked at the UK National Blood Service (now NHSBT) at their Birmingham, UK, laboratories. He then took up a technical support role at DuPont Virology Diagnostics before moving into commercial roles at Kendro Laboratory Products and Thermo Fisher Scientific.

In 2004 he set up the Thermo Fisher Bioservices facility in Bishops Stortford, UK, and directed the business as General Manager, supporting the supply chain of over 100 advanced therapy clinical trials from Phase I to Phase III.

He joined Cryoport in 2018 and is responsible for the strategic expansion of Cryoport's Bioservices business and oversees the introduction of new facilities and services in the field of critical supply chain support.

His main areas of interest are advanced therapy supply chain management, cryogenic storage and packaging, and the development of innovation and technology in ultra-low temperature and cryogenic workflows.

He is a Fellow of the Institute of Biomedical Scientists, Member of the Royal Society of Biology and Member of the Institute of Clinical Research.

John Phillips

Global Vice President, Reproductive Medicine

Having more than 30 years of experience in sales and development of information technology and consulting services, John is responsible for the global expansion of Cryoport’s Reproductive Medicine vertical market. Prior to joining Cryoport, Mr. Phillips was with Windstream Communications where he was responsible for the development, strategic positioning and implementation of Windstream's Enterprise Managed Services offering. Previous to Windstream, Mr. Phillips acted in several leadership positions at CBIZ where he architected key business policies and alliances that accelerated strong revenue growth. Mr. Phillips began his career with Xerox Corporation where he successfully served in various business development positions. John has a B.S. degree in Business from Oral Roberts University and lives with his wife in Tulsa, OK.